Plunkett Research Online: Innovent Biologics Inc

INNOVENT BIOLOGICS INC (IVBXF:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Innovent is a China-based biotechnology company that is developing drugs for a wide array of diseases, especially oncology therapeutics. Founded in 2011, it listed on the Hong Kong Stock Exchange in 2018. Its core asset is a PD-1 inhibitor called Tyvyt or sinitilimab. It also has a portfolio of thre.....



Innovent Biologics Inc
Ticker: IVBXF
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 86 51269566088
Fax: 86 51269566088
Address: 168 Dongping Street
Suzhou Industrial Park, Jiangsu
Suzhou, 215123 China

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Biotechnology

Ranks not available
Contacts Description
De-Chao YuCEO/Chairman of the Board/Director/Founder
Hao Xi EdeDirector
See More
Innovent is a China-based biotechnology company that is developing drugs for a wide array of diseases, especially oncology therapeutics. Founded in 2011, it listed on the Hong Kong Stock Exchange in 2018. Its core asset is a PD-1 inhibitor called Tyvyt or sinitilimab. It also has a portfolio of thre.....See More See More

Auditor: Deloitte Touche Tohmatsu
Legal Advisor:
$USD, In whole numbers,
except marked * or %
202320222021202020192018
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: